GENERAL ATLANTIC L.P. 13D and 13G filings for Immunocore Holdings plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-03-07 9:45 pm Sale | 2024-03-07 | 13D | Immunocore Holdings plc IMCR | GENERAL ATLANTIC L.P. | 1,747,849 3.500% | -858,835 (-32.95%) | Filing |
2023-09-18 2:40 pm Sale | 2023-09-15 | 13D | Immunocore Holdings plc IMCR | GENERAL ATLANTIC L.P. | 2,606,684 5.300% | -249,213 (-8.73%) | Filing |
2023-06-15 5:17 pm Sale | 2023-06-13 | 13D | Immunocore Holdings plc IMCR | GENERAL ATLANTIC L.P. | 2,855,897 5.900% | -369,803 (-11.46%) | Filing |
2023-01-17 5:25 pm Sale | 2022-01-12 | 13D | Immunocore Holdings plc IMCR | GENERAL ATLANTIC L.P. | 3,225,700 7.100% | -614,969 (-16.01%) | Filing |
2023-01-03 6:56 pm Sale | 2022-12-29 | 13D | Immunocore Holdings plc IMCR | GENERAL ATLANTIC L.P. | 3,840,669 8.480% | -516,223 (-11.85%) | Filing |
2022-12-20 5:13 pm Sale | 2022-12-16 | 13D | Immunocore Holdings plc IMCR | GENERAL ATLANTIC L.P. | 4,356,892 9.620% | -965,683 (-18.14%) | Filing |
2022-07-21 5:13 pm Purchase | 2022-07-20 | 13D | Immunocore Holdings plc IMCR | GENERAL ATLANTIC L.P. | 5,322,575 11.500% | 5,322,575 (New Position) | Filing |